↓ Skip to main content

A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®

Overview of attention for article published in Trials, October 2021
Altmetric Badge

Mentioned by

blogs
1 blog
twitter
5 X users

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
66 Mendeley